BREAKING
Atour Lifestyle Reports $0.33 Q4 EPS, Down 86.1% YoY, as Revenue Surges 33.8% to $2.79B 9 minutes ago TME Earnings Miss: Q4 EPS of $0.23 Falls Short of Estimates 23 minutes ago XOMA Reports Wednesday Morning as Healthcare Earnings Dominate Sparse Week 46 minutes ago HUYA Stock Plunges: Q4 Revenue Crashes 83.4% YoY to $248.6M, Misses EPS by 106.5% 52 minutes ago Monte Rosa (GLUE) Reports Wider Q4 Loss of $0.55/Share vs $0.34 Estimate, Revenue Misses 1 hour ago Monte Rosa Therapeutics, Inc. (GLUE) Reports Wider Loss Q4 EPS Estimates by 63.4% 1 hour ago Coda Octopus (CODA) Beats Q1 Estimates with $0.08 EPS, Revenue Surges 28.6% YoY to $6.7M 1 hour ago Bicycle Therapeutics (BCYC) Q4 Revenue Soars 1194.5% YoY to $48M, Crushing Estimates by 578% 1 hour ago Getty Images (GETY) Q4 Revenue Surges 14.1% YoY to $282.3M 2 hours ago FINV Stock: 8 Analysts Issue Buy-or-Better Ratings as FinVolution Delivers $0.25 EPS on Flat Revenue 2 hours ago Atour Lifestyle Reports $0.33 Q4 EPS, Down 86.1% YoY, as Revenue Surges 33.8% to $2.79B 9 minutes ago TME Earnings Miss: Q4 EPS of $0.23 Falls Short of Estimates 23 minutes ago XOMA Reports Wednesday Morning as Healthcare Earnings Dominate Sparse Week 46 minutes ago HUYA Stock Plunges: Q4 Revenue Crashes 83.4% YoY to $248.6M, Misses EPS by 106.5% 52 minutes ago Monte Rosa (GLUE) Reports Wider Q4 Loss of $0.55/Share vs $0.34 Estimate, Revenue Misses 1 hour ago Monte Rosa Therapeutics, Inc. (GLUE) Reports Wider Loss Q4 EPS Estimates by 63.4% 1 hour ago Coda Octopus (CODA) Beats Q1 Estimates with $0.08 EPS, Revenue Surges 28.6% YoY to $6.7M 1 hour ago Bicycle Therapeutics (BCYC) Q4 Revenue Soars 1194.5% YoY to $48M, Crushing Estimates by 578% 1 hour ago Getty Images (GETY) Q4 Revenue Surges 14.1% YoY to $282.3M 2 hours ago FINV Stock: 8 Analysts Issue Buy-or-Better Ratings as FinVolution Delivers $0.25 EPS on Flat Revenue 2 hours ago
ADVERTISEMENT
Analysis

Perella Weinberg Shares Gain After Q4 Earnings Beat; Full-Year Revenue Falls From 2024 Record

February 6, 2026 2 min read

Perella Weinberg Partners L.

Stock Reaction and Trading Context

Fourth-Quarter Results

In Q4 2025, Perella Weinberg reported revenues of $219.2 million. That’s down 3% from $225.7 million in Q4 2024, but up a strong 33% from the previous quarter. GAAP pre-tax income hit $22 million, while adjusted pre-tax income reached $29 million. Meanwhile, GAAP diluted EPS was $0.10, and adjusted EPS came in at $0.17. Compensation and benefits expenses rose to $161.5 million, compared to $156.1 million a year earlier. Overall, total quarterly expenses totaled $200.6 million.

Full-Year 2025 Performance

For the full year 2025, revenues fell 14% to $750.9 million from a record $878.0 million in 2024. GAAP pre-tax income was $52 million, but adjusted pre-tax income improved to $82 million. GAAP diluted EPS stood at $0.47, with adjusted EPS at $0.68. On expenses, full-year compensation and benefits dropped to $535.4 million from $784.2 million in 2024. Total annual expenses were $702.9 million.

 

Capital and Balance Sheet

The firm wrapped up 2025 with a solid $256 million in cash and zero debt. Additionally, during the year, Perella Weinberg retired over 6 million shares and returned $163 million to equity holders.

 

Talent and Strategic Moves

Perella Weinberg grew its team by adding 12 partners and 11 managing directors in 2025. In fact, it has already welcomed two more partners in early 2026. Strategically, the firm also acquired Devon Park Advisors to expand into secondaries advisory.

 

Analyst Reactions

No analyst upgrades, downgrades, or price-target changes appeared alongside the earnings release.

 

Year-on-Year Perspective

Overall, results dipped from 2024’s record advisory boom, driven by fewer large-deal closings. That said, sequential quarterly growth, ongoing hiring, and strategic additions position the firm well for an advisory recovery.

ADVERTISEMENT